Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
IOVA
IOVA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
IOVA News
Iovance Biotherapeutics Unveils New Data on Amtagvi Therapy
Feb 05 2026
Newsfilter
Iovance Biotherapeutics Stock Sentiment and Revenue Outlook
Jan 26 2026
stocktwits
Iovance Biotherapeutics Grants 97,710 Stock Options to Attract New Employees
Jan 16 2026
Globenewswire
Iovance and Others Face Shareholder Lawsuits Seeking Governance Reforms
Jan 12 2026
Globenewswire
Intellia and Iovance Stocks Plummet, Analysts See Potential Upside
Dec 29 2025
Fool
Intellia and Iovance Face Major Challenges as Stocks Plummet
Dec 29 2025
NASDAQ.COM
Iovance Grants 43,150 Stock Options to Attract New Employees
Dec 19 2025
Newsfilter
Iovance Grants 43,150 Stock Options to Attract New Employees
Dec 19 2025
Globenewswire
Iovance Biotherapeutics Announces Inducement Grants in Compliance with NASDAQ Listing Rule 5635(c)(4)
Dec 19 2025
Yahoo Finance
Iovance (IOVA) Third Quarter 2025 Earnings Call Summary
Nov 27 2025
NASDAQ.COM
Oncotelic Raises GMP Bio Valuation to $1.7 Billion
Nov 24 2025
Newsfilter
Biotech Valuations Increase as Innovative Clinical Platforms Demonstrate Advancement
Nov 24 2025
Globenewswire
Iovance Biotherapeutics Announces Inducement Grants in Compliance with NASDAQ Listing Rule 5635(c)(4)
Nov 21 2025
Newsfilter
Chardan Capital Reaffirms Buy Rating for Iovance Biotherapeutics, Adjusts Price Target to $17
Nov 06 2025
Benzinga
Iovance aims for over $1 billion in U.S. peak sales for Amtagvi as production moves to in-house facility.
Nov 06 2025
SeekingAlpha
Iovance Shares Surge 34% Following Strong Q3 Earnings and Robust Amtagvi Sales
Nov 06 2025
SeekingAlpha
Show More News
